Benitec Relocates to Sydney, Receives Notice of Allowance for US Patent Application | GenomeWeb

Benitec said this week that it has relocated its headquarters from Melbourne to Sydney in Australia.

According to the company, its CEO Peter French is based in Sydney.

The company also announced that it has received notice from the US Patent and Trademark Office that it will receive a patent on an application, No.20030159161, from its Graham patent family, which broadly covers its core expressed RNAi technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.